JNJ-7706621 ≥95%
Supplier: ADIPOGEN CORP MS
Synonyms:
Aurora Kinase/Cdk Inhibitor, 4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulphonamide, 4-(5-Amino-1-(2,6-difluorobenzoyl)-1H-[1,2,4]triazol-3-ylamino)-benzenesulphonamide, Aurora A Inhibitor I
SYN-1048-M001
SYN-1048-M005
SYN-1048-M010
SYN-1048-M050
102991-622EA
186.92
USD
102991-622
102991-624
102991-626
102991-628
JNJ-7706621 ≥95%
JNJ-7706621
JNJ-7706621 is a dual inhibitor of cyclin-dependent kinases (CDK) and aurora kinases. It demonstrates highest potency on CDK1/2 with IC(50) values of 9nM and 4nM respectively. It shows more than 6-fold selectivity for CDK1/2 over CDK3/4/6.
Formula:
C₁₅H₁₂F₂N₆O₃S MW: 394.36 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD11100270 CAS Number: 443797-96-4 |
Specification Test Results
Purity | >95% |
Appearance/Color | Solid. |
Solubility | Soluble in DMSO or ethanol. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...